Sunday, July 25, 2021

Moderna begins testing on its new COVID-19 vaccine candidate

Must Read

Astım Tedavisinde Ailelerin Kortizon Korkusu

Baharın gelmesiyle birlikte parfüm kullanımında artış görülüyor. Ancak astım hastalarının dikkatli olmalarında fayda var; çünkü parfümlerin çoğu güvenli...

Alerjik Hastalıklara Kesin Çözüm

Kortizon deyince tedavisinden ziyade yan etkileri akla geliyor. Ancak alerjik bronşit ya da diğer adıyla astım ataklarının önlenmesinde...

Alerjik Hastalıklara Kesin Çözüm

Alerji; insanın savunma sisteminin genellikle zararsız maddelere karşı verdiği abartılı tepkidir ve genellikle çocukluk çağında başlayarak uzun yıllar, hatta...
- Advertisement -
- Advertisement -

Moderna Inc. mentioned on Monday it had dosed the first player in an early-degree observe of a new -19 vaccine candidate that would doubtlessly be saved and shipped in refrigerators in preference to freezers.

the company stated its new candidate could make it more uncomplicated for distribution, particularly in creating nations where provide chain issues could hamper vaccination drives.

early-level study will investigate the security and immunogenicity of the following-technology vaccine, special as mRNA-1283, at 3 dose levels, and can take delivery of to photooftheday adults either as a single dose, or in two doses 28 days aside, the company mentioned.

We simply introduced that the first individuals were dosed within the Phase 1 study of mRNA-1283, our next technology -19 vaccine candidate. Learn extra: https://t.co/jRR5FLAgiW pic.twitter.com/ONXeHSTCjI

—@moderna_tx

Moderna also plans to evaluate the brand new vaccine, mRNA-1283, as a possible booster shot in long term research.

Remaining week, Moderna began dosing the primary participants in a observe trying out ME-19 booster vaccine applicants focused on version, known as B.1.351, that used to be first detected in South Africa.

Moderna says vaccine appears efficient against new coronavirus versions — but less so for oneTrudeau says AstraZeneca vaccine is safe after a few Eu nations droop its use

booster vaccine applicants, unique mRNA-1273.351, will probably be examined in a trial of both a variation-specific shot and a multivalent shot, in step with the company’s announcement.

Moderna’s first vaccine (mRNA-1273) was once approved for use by means of Canada on Dec. 23.

- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News

Astım Tedavisinde Ailelerin Kortizon Korkusu

Baharın gelmesiyle birlikte parfüm kullanımında artış görülüyor. Ancak astım hastalarının dikkatli olmalarında fayda var; çünkü parfümlerin çoğu güvenli...

More Articles Like This